secwatch.observer — SEC 8-K summary
======================================

Issuer:     Century Therapeutics, Inc. (IPSC)
CIK:        0001850119
Form:       8-K
Filed at:   2026-01-08T23:59:59+00:00
Accession:  0001104659-26-001952
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Century Therapeutics raises $135M in oversubscribed private placement to fund CNTY-813 T1D program
--------------------------------------------------------------------------------

- Gross proceeds ~$135M; 117.4M shares/pre-funded warrants + 58.7M warrants at $1.15 per unit.
- Led by new investor TCGX; includes RA Capital, Commodore, Deep Track, RTW, Venrock, T1D Fund.
- Proceeds fund lead candidate CNTY-813 (beta islet cell for T1D); cash runway extended to Q1 2029.
- IND submission for CNTY-813 expected in 2026; initial clinical data anticipated in 2027.
- Full exercise of warrants could yield additional ~$153M at $2.60 per share.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850119/000110465926001952/0001104659-26-001952-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850119/000110465926001952/tm262422d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-001952

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer